4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Affiliations

Showing 9 results for affiliation "Eli Lilly and Company".

Back to affiliations

Thumbnail for Evaluation Of Diffusion Tensor Imaging Biomarkers In Phase 2 PROSPECT-ALZ Study Of Ceperognastat In Early Symptomatic Alzheimer’s Disease

10000

Evaluation Of Diffusion Tensor Imaging Biomarkers In Phase 2 PROSPECT-ALZ Study Of Ceperognastat In Early Symptomatic Alzheimer’s Disease

Ajay Kurani, Diana Svaldi Otero, Vikas Kotari, Jiaying Guo, Min Jung Kim, Hugh Nuthall, Adam S Fleisher, Oskar Hansson, Sergey Shcherbinin

Eli Lilly and Company

Poster Presenter: Ajay Kurani

Thumbnail for Regional Tau Pet Extent To Estimate Pathological Volume, Capture Tau Heterogeneity, And Detect Treatment Response In Clinical Trials

10381

Regional Tau Pet Extent To Estimate Pathological Volume, Capture Tau Heterogeneity, And Detect Treatment Response In Clinical Trials

Vikas Kotari, Karen C. Holdridge, Roy Yaari, Emily C. Collins, Leanne M. Munsie, Adam S. Fleisher, Oskar Hansson, John R. Sims, Rik Ossenkoppele, Sergey Shcherbinin

Eli Lilly and Company

Poster Presenter: Vikas Kotari

Thumbnail for Defining Meaningful Change In Alzheimer’S Disease Through Lived Experience: Implications For The Clinical Dementia Rating Scale

13336

Defining Meaningful Change In Alzheimer’S Disease Through Lived Experience: Implications For The Clinical Dementia Rating Scale

J. Scott Andrews, Carla DeMuro, Alette Wessels, Jacquie Mogle, Nalin Payakachat, Audra Gold, Sean Halpin, Antje Tockhorn-Heidenreich, Emily Bratlee-Whitaker, Alice Farquharson, Niklas Mattso...

Eli Lilly and Company, RTI Health Solutions, Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Medical Faculty, Lund University, Lund, Sweden

Poster Presenter: Jeffrey Andrews

5433

Data-driven Feature Map Associating Baseline Florbetapir-PET Uptake Patterns To Aria-E Incidence

Ian Kennedy, Min Jung Kim, Ming Lu, Emily Collins, John Sims, Mark Mintun, Sergey Shcherbinin

Eli Lilly and Company

Poster Presenter: Ian Kennedy

8700

Evaluating the Feasibility and Acceptability of Goal Attainment Scaling in Heterogeneous Alzheimer’s Disease Populations

Gunes Sevinc, Lois Kelly, Hampus Hillerstorm, James Hendrix, Arlene Kelly-Wiggins, Chere Chapman, Kenneth Rockwood

Eli Lilly and Company, Ardea Outcomes, Dalhousie University, National Down Syndrome Society, Nova Scotia Health Authority

Poster Presenter: Chere Chapman

Thumbnail for Natural Language Processing Of Imaging Reports To Identify Intracerebral Hemorrhage>1cm And Amyloid-related Imaging Abnormalities

8947

Natural Language Processing Of Imaging Reports To Identify Intracerebral Hemorrhage>1cm And Amyloid-related Imaging Abnormalities

Laura Schott, Zhun Cao, Sunday Ikpe, Ben Davis, Ann Hartry, Krista Schroeder

Eli Lilly and Company, Premier, Inc.

Poster Presenter: Krista Schroeder

Thumbnail for Interim Analysis Of The United Kingdom Donanemab Controlled Access Programme: Early Patient Characteristics And Prescribing Patterns

8953

Interim Analysis Of The United Kingdom Donanemab Controlled Access Programme: Early Patient Characteristics And Prescribing Patterns

Elsie Grace, Krista Schroeder, Rashna Khanna, Niraj Patel

Eli Lilly and Company

Poster Presenter: Krista Schroeder

9036

Neurocognitive, Biomarker, And Health Outcomes In Those At Risk For Alzheimer’s Disease Symptoms: ANCHOR-AD Study Design

Sterling Johnson, Nalin Payakachat, Michelle Mielke, Kellen Petersen, Alette Wessels, Jolanda Muenzel, Dulanji Kuruppu, Rose Beck, Scott Andrews, Yoshiki Niimi, Roy Yaari, Takeshi Iwatsubo,...

Wake Forest University School of Medicine, Eli Lilly and Company, Washington University School of Medicine, University of Wisconsin, University of Tokyo Hospital, University of Tokyo National Center of Neurolog...

Poster Presenter: Nalin Payakachat

9046

Cross-sectional Evaluation Of Diffusion Tensor Imaging Endpoints Using Three Clinical Trials In Alzheimer’S Disease

Diana Otero, Ilke Tunali, Ajay Kurani, David Aurey, Jiahe Li, Isabel Xu, Jiaying Guo, Hong Wang, Emel Nery, Emily Collins, Adam Fleisher, Kevin Biglan, John Sims, Sergey Shcherbinin

Eli Lilly and Company

Poster Presenter: Diana Otero